Prosecution Insights
Prosecution Insights
25 pending office actions • 5 clients • 25 examiners • 20 art units • 0 of 25 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (4%) |
| §103 only | 10 (40%) |
| §112 only | 1 (4%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 12 (48%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DANG, RACHEL YEN VI | 1 | 100.0% | +0.0% |
| KWAK, DEAN P | 1 | 58.8% | +37.2% |
| REGA, KYLE THOMAS | 1 | 61.8% | +40.7% |
| KIM, SEONG JONG | 1 | — | — |
| STONEBRAKER, ALYSSA RAE | 1 | 56.1% | +48.8% |
| BERKE-SCHLESSEL, DAVID W | 1 | 66.6% | +31.9% |
| KETCHAM, KAREN A | 1 | 17.6% | +32.5% |
| IQBAL, SYED TAHA | 1 | 80.0% | +21.7% |
| SODERQUIST, ARLEN | 1 | 59.8% | +26.5% |
| LIPPERT, JOHN WILLIAM | 1 | 56.6% | +41.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18273658 | METHODS AND SYSTEMS FOR PRODUCING DISPERSED GRAPHENE FROM SPENT LITHIUM-ION BATTERIES | IQBAL, SYED TAHA | 51d overdue |
| 18854483 | AUTOMATION OF THE BLOOD INPUT FUNCTION COMPUTATION PIPELINE FOR DYNAMIC FDG PET FOR HUMAN BRAIN USING MACHINE LEARNING | DANG, RACHEL YEN VI | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17637557 | DDX17 AND NLRC4 TARGETING FOR INFLAMMATORY DISEASES | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 162d overdue |
| 18316981 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY | HUDSON, AMY ROSE | 127d overdue |
| 18277676 | GUEST-HOST SUPRAMOLECULAR ASSEMBLY OF INJECTABLE HYDROGEL NANOFIBERS FOR CELL ENCAPSULATION | BERKE-SCHLESSEL, DAVID W | 118d overdue |
| 16097024 | SYSTEMS, METHODS, AND COMPUTER READABLE MEDIA FOR ISCHEMIC INJURY PROTECTIVE ULTRASOUND | COOK, CHRISTOPHER L | 49d overdue |
| 17436882 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE | RAMOS LEWIS, JOSMALEN MILAGROS | 45d overdue |
| 17799149 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR DISORDERS | ADLAM, CHANTAL PETA-GAYE | 2d overdue |
| 18011412 | TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19 | KIM, YUNSOO | 1d overdue |
| 18495741 | SUGAR-CONJUGATED LIPID NANOPARTICLES AND METHODS OF USE THEREFOR | REGA, KYLE THOMAS | 28d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18277676 | GUEST-HOST SUPRAMOLECULAR ASSEMBLY OF INJECTABLE HYDROGEL NANOFIBERS FOR CELL ENCAPSULATION | BERKE-SCHLESSEL, DAVID W | 118d overdue |
| 18037684 | MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME | LIPPERT, JOHN WILLIAM | 89d overdue |
| 18273658 | METHODS AND SYSTEMS FOR PRODUCING DISPERSED GRAPHENE FROM SPENT LITHIUM-ION BATTERIES | IQBAL, SYED TAHA | 51d overdue |
| 18495741 | SUGAR-CONJUGATED LIPID NANOPARTICLES AND METHODS OF USE THEREFOR | REGA, KYLE THOMAS | 28d |
| 18279193 | DEVELOPMENT OF COVID-19 VACCINE USING A DUAL TLR LIGAND LIPOSOME ADJUVANT | STONEBRAKER, ALYSSA RAE | 53d |
| 18273728 | ALTERING PROTEIN FUNCTION BY PHARMACOLOGICAL TARGETING OF MEMBRANE DOMAINS | SODERQUIST, ARLEN | 53d |
| 18276111 | COMPOSITIONS AND METHODS FOR TARGETED ANTIFIBROTIC THERAPY IN CHRONIC PANCREATITIS | KETCHAM, KAREN A | 70d |
| 18684561 | METHODS, SYSTEMS AND COMPOSITIONS FOR THE PREDICTION AND PREVENTION OF PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS USING FECAL BIOMARKERS | KWAK, DEAN P | — |
| Client (Assignee) | Pending OAs |
|---|---|
| UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 21 |
| Inova Health Care Services | 1 |
| Anna Pomés | 1 |
| VANDERBILT UNIVERSITY | 1 |
| Virginia Tech | 1 |
| Art Unit | Apps |
|---|---|
| 1636 | 2 |
| 1621 | 2 |
| 1644 | 2 |
| 1622 | 2 |
| 2668 | 1 |
| 1642 | 1 |
| 1651 | 1 |
| 1614 | 1 |
| 1736 | 1 |
| 1797 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18854483 | AUTOMATION OF THE BLOOD INPUT FUNCTION COMPUTATION PIPELINE FOR DYNAMIC FDG PET FOR HUMAN BRAIN USING MACHINE LEARNING | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | DANG, RACHEL YEN VI | 2668 | §103 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18684561 | METHODS, SYSTEMS AND COMPOSITIONS FOR THE PREDICTION AND PREVENTION OF PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS USING FECAL BIOMARKERS | Inova Health Care Services | KWAK, DEAN P | §112 | Non-Final OA | — | Pending | Feb 16, 2024 | |
| 18495741 | SUGAR-CONJUGATED LIPID NANOPARTICLES AND METHODS OF USE THEREFOR | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | REGA, KYLE THOMAS | 1636 | §102§103§112Other | Non-Final OA | 28d | Pending | Oct 26, 2023 |
| 18281528 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING THERAPY-RELATED CARDIOMYOPATHY ASSOCIATED WITH NEUTROPHIL INFILTRATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | KIM, SEONG JONG | 1621 | §101§103§112 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18279193 | DEVELOPMENT OF COVID-19 VACCINE USING A DUAL TLR LIGAND LIPOSOME ADJUVANT | Anna Pomés | STONEBRAKER, ALYSSA RAE | 1642 | §103§112Other | Non-Final OA | 53d | Pending | Aug 28, 2023 |
| 18277676 | GUEST-HOST SUPRAMOLECULAR ASSEMBLY OF INJECTABLE HYDROGEL NANOFIBERS FOR CELL ENCAPSULATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | BERKE-SCHLESSEL, DAVID W | 1651 | §103§112 | Final Rejection | 118d overdue | Pending | Aug 17, 2023 |
| 18276111 | COMPOSITIONS AND METHODS FOR TARGETED ANTIFIBROTIC THERAPY IN CHRONIC PANCREATITIS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | KETCHAM, KAREN A | 1614 | §103 | Non-Final OA | 70d | Pending | Aug 07, 2023 |
| 18273658 | METHODS AND SYSTEMS FOR PRODUCING DISPERSED GRAPHENE FROM SPENT LITHIUM-ION BATTERIES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | IQBAL, SYED TAHA | 1736 | §103 | Final Rejection | 51d overdue | Pending | Jul 21, 2023 |
| 18273728 | ALTERING PROTEIN FUNCTION BY PHARMACOLOGICAL TARGETING OF MEMBRANE DOMAINS | VANDERBILT UNIVERSITY | SODERQUIST, ARLEN | 1797 | §103§112 | Non-Final OA | 53d | Pending | Jul 21, 2023 |
| 18037684 | MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | 89d overdue | Pending | May 18, 2023 |
| 18316981 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | HUDSON, AMY ROSE | 1636 | §103§112 | Final Rejection | 127d overdue | Pending | May 12, 2023 |
| 18027202 | 3D-PRINTED MODULAR MICROCHIP WITH AN INTEGRATED IMPELLER PUMP TO MODEL INTER-ORGAN COMMUNICATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | GIERE, REBECCA M | 1677 | §103 | Final Rejection | 5d overdue | Pending | Mar 20, 2023 |
| 18011412 | TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19 | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | KIM, YUNSOO | 1641 | §102§103Other | Non-Final OA | 1d overdue | Pending | Dec 19, 2022 |
| 17924963 | COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES AGAINST CLASS I FUSION PROTEIN VIRUSES | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | SINGH, SATYENDRA K | 1657 | §103§112DP | Final Rejection | — | Pending | Nov 11, 2022 |
| 17910613 | METABOLITES RELEASED FROM APOPTOTIC CELLS ACT AS NOVEL TISSUE MESSENGERS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | BARSKY, JARED | 1628 | §103 | Final Rejection | 78d overdue | Pending | Sep 09, 2022 |
| 17800387 | CAR T CELLS TARGETING THE INTEGRIN ALPHAV BETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST GLIOMAS AND OTHER SOLID TUMOR MALIGNANCIES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | BELYAVSKYI, MICHAIL A | 1644 | §103 | Final Rejection | — | Pending | Aug 17, 2022 |
| 17799149 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR DISORDERS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | ADLAM, CHANTAL PETA-GAYE | 1622 | §103§112Other | Final Rejection | 2d overdue | Pending | Aug 11, 2022 |
| 17769899 | COMPOSITIONS AND METHODS FOR PRODUCING ENHANCED IMMUNE RESPONSES AND RAPID ANTIBODY PRODUCTION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | MORGAN, BAILEY MICHELLE | 1645 | §103 | Non-Final OA | — | Pending | Apr 18, 2022 |
| 17763798 | COMPOSITIONS AND METHODS FOR PREVENTING AND/OR REDUCING WEIGHT GAIN AND ASSOCIATED CONDITIONS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §103 | Final Rejection | — | Pending | Mar 25, 2022 |
| 17637557 | DDX17 AND NLRC4 TARGETING FOR INFLAMMATORY DISEASES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | §102§103§112 | Non-Final OA | 162d overdue | Pending | Feb 23, 2022 |
| 17632349 | BISPECIFIC ANTIBODY TARGETING OF T REGULATORY CELLS FOR TREATMENT OF INFLAMMATORY CONDITIONS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | OUSPENSKI, ILIA I | 1644 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2022 |
| 17630106 | COMPOSITIONS AND METHODS FOR INHIBITING NEOINTIMAL FORMATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | COFFA, SERGIO | 1658 | §103§112 | Non-Final OA | — | Pending | Jan 25, 2022 |
| 17436882 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | §102§103§112 | Final Rejection | 45d overdue | Pending | Sep 07, 2021 |
| 17045459 | 3D SPATIALLY PATTERNED LYMPH NODE ON A MICROFLUIDIC DEVICE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | JOHNSON, KARA D | 1632 | §103 | Non-Final OA | — | Pending | Oct 05, 2020 |
| 16097024 | SYSTEMS, METHODS, AND COMPUTER READABLE MEDIA FOR ISCHEMIC INJURY PROTECTIVE ULTRASOUND | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | COOK, CHRISTOPHER L | 3797 | §103§112 | Non-Final OA | 49d overdue | Pending | Oct 26, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial